Department of Signal Transduction, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Invest Ophthalmol Vis Sci. 2022 Apr 1;63(4):5. doi: 10.1167/iovs.63.4.5.
CD157 (also known as Bst1) positive vascular endothelial stem cells (VESCs), which contribute to vascular regeneration, have been recently identified in mouse organs, including the retinas, brain, liver, lungs, heart, and skin. However, VESCs have not been identified in the choroid. The purpose of this study was to identify VESCs in choroidal vessels and to establish the protocol to isolate retinal and choroidal VESCs.
We established an efficient protocol to create single-cell suspensions from freshly isolated mouse retina and choroid by enzymatic digestion using dispase, collagenase, and type II collagenase. CD157-positive VESCs, defined as CD31+CD45-CD157+ cells, were sorted using fluorescence-activated cell sorting (FACS).
In mouse retina, among CD31+CD45- endothelial cells (ECs), 1.6 ± 0.2% were CD157-positive VESCs, based on FACS analysis. In mouse choroid, among CD31+CD45- ECs, 4.5 ± 0.4% were VESCs. The CD157-positive VESCs generated a higher number of EC networks compared with CD157-negative non-VESCs under vascular endothelial growth factor (VEGF) in vitro cultures. The EC network area, defined as the ratio of the CD31-positive area to the total area in each field, was 4.21 ± 0.39% (retinal VESCs) and 0.27 ± 0.12% (retinal non-VESCs), respectively (P < 0.01). The EC network area was 8.59 ± 0.78% (choroidal VESCs) and 0.14 ± 0.04% (choroidal non-VESCs), respectively (P < 0.01). The VESCs were located in large blood vessels but not in the capillaries.
We confirmed distinct populations of CD157-positive VESCs in both mouse retina and choroid. VESCs are located in large vessels and have the proliferative potential. The current results may open new avenues for the research and treatment of ocular vascular diseases.
CD157(也称为 Bst1)阳性血管内皮干细胞(VESCs)有助于血管再生,最近在包括视网膜、脑、肝、肺、心和皮肤在内的小鼠器官中被发现。然而,脉络膜中尚未发现 VESCs。本研究的目的是鉴定脉络膜血管中的 VESCs,并建立分离视网膜和脉络膜 VESCs 的方案。
我们通过使用Dispase、胶原酶和 II 型胶原酶进行酶消化,建立了从新鲜分离的小鼠视网膜和脉络膜中创建单细胞悬浮液的有效方案。CD157 阳性 VESCs 定义为 CD31+CD45-CD157+细胞,使用荧光激活细胞分选(FACS)进行分选。
在小鼠视网膜中,根据 FACS 分析,在 CD31+CD45-内皮细胞(ECs)中,1.6±0.2%为 CD157 阳性 VESCs。在小鼠脉络膜中,在 CD31+CD45-ECs 中,4.5±0.4%为 VESCs。在体外培养血管内皮生长因子(VEGF)下,CD157 阳性 VESCs 比 CD157 阴性非 VESCs 生成更多的 EC 网络。EC 网络面积定义为每个视野中 CD31 阳性区域与总区域的比值,分别为 4.21±0.39%(视网膜 VESCs)和 0.27±0.12%(视网膜非 VESCs)(P<0.01)。EC 网络面积分别为 8.59±0.78%(脉络膜 VESCs)和 0.14±0.04%(脉络膜非 VESCs)(P<0.01)。VESCs 位于大血管中,但不在毛细血管中。
我们在小鼠视网膜和脉络膜中均证实了 CD157 阳性 VESCs 的不同群体。VESCs 位于大血管中,具有增殖潜力。目前的结果可能为眼部血管疾病的研究和治疗开辟新途径。